Dear Prof. Aleksandr Shulyak,
MRI is increasingly used in the diagnosis of prostate cancer. Here, it is especially used to identify suspicious lesions inside the prostate. Those lesions are then considered as targets during ultrasound guided biopsy. Targeting can be done either based on the operator’s skills to localize the lesion inside of the prostate, called cognitive fusion, or by using specific technical devices allowing MRI and ultrasound image fusion.
Experts Dr. Jochen Walz (urologist) and Dr. Jurgen Fütterer (radiologist) are hosting a webinar on fusion biopsy: To Fuse or Not to Fuse? The webinar will discuss several aspects of the MRI-based prostate cancer diagnostic pathway; address advantages and limitations of MRI; and examine the advantages and disadvantages of the cognitive and the MRI-ultrasound fusion approaches.
The seminar will take place online as part of the EAU’s successful UROwebinar series, and also allow for the online audience to take part in the discussion. It follows previous topics like bladder cancer management, robotic kidney transplantation and prostate cancer screening.
Join us for this webinar on Jan 25, 2017 at 6:30 PM CET.
